Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa

Azwidihwi Takalani, Michelle Robinson, Phumeza Jonas, Annie Bodenstein, Vuyelo Sambo,Barry Jacobson,Vernon Louw,Jessica Opie,Jonny Peter,Pradeep Rowji,Ishen Seocharan,Tarylee Reddy,Nonhlanhla Yende-Zuma, Kentse Khutho,Ian Sanne,Linda-Gail Bekker,Glenda Gray,Nigel Garrett,Ameena Goga

Vaccine（2024）

引用 0|浏览5

暂无评分

摘要

The Sisonke 2 study provided a homologous boost at least 6 months after administration of the priming dose of Ad26.COV2.S for healthcare workers enrolled on the Sisonke phase 3b implementation study.

查看译文

关键词

Ad26.COV2.S,Sisonke study,Vaccine safety,Pharmacovigilance,Homologous boost

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要